Aurinia Pharmaceuticals Inc. - 8-K Filing
On June 3, 2026, Aurinia Pharmaceuticals Inc. held its annual general meeting where shareholders elected five board members with vote percentages ranging from 86.5% to 96.59%, approved PricewaterhouseCoopers LLP as the independent auditor (with 94.14% approval), and passed a non-binding 'say on pay' resolution regarding executive compensation (approved by 93.1%).
Tickers: $AUPH